Common Contracts
4 similar Credit Agreement contracts by Amryt Pharma PLC, Purple Innovation, Inc.
AMENDED AND RESTATED CREDIT AGREEMENT Dated as of January 23, 2024 among PURPLE INNOVATION, LLC, as a Borrower, PURPLE INNOVATION, INC., as Guarantor, CERTAIN FINANCIAL INSTITUTIONS, as Lenders, and DELAWARE TRUST COMPANY, as Administrative AgentCredit Agreement • January 23rd, 2024 • Purple Innovation, Inc. • Household furniture • New York
This AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”) is entered into as of January 23, 2024, among PURPLE INNOVATION, LLC, a Delaware limited liability company (the “Company” or “Borrower” and collectively with any other entities that become a “Borrower” hereunder, the “Borrowers”), PURPLE INNOVATION, INC., a Delaware corporation (“Holdings”), EACH LENDER FROM TIME TO TIME PARTY HERETO (collectively, the “Lenders” and individually, a “Lender”), and DELAWARE TRUST COMPANY, as Administrative Agent.
CREDIT AGREEMENTCredit Agreement • June 23rd, 2020 • Amryt Pharma PLC • Pharmaceutical preparations • New York
This CREDIT AGREEMENT (this “Agreement”) is entered into as of September 24, 2019 among AEGERION PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), AMRYT PHARMA HOLDINGS PLC, a company incorporated in England and Wales with company number 12107859 (to be renamed on or around the date hereof as AMRYT PHARMA PLC) (the “Parent”), each Lender (as hereinafter defined) from time to time party hereto and CANTOR FITZGERALD SECURITIES, as administrative agent and collateral agent for the Lenders (in such capacities, together with any successor administrative agent and collateral agent, the “Administrative Agent”).
CREDIT AGREEMENTCredit Agreement • May 11th, 2020 • Amryt Pharma PLC • Pharmaceutical preparations • New York
This CREDIT AGREEMENT (this “Agreement”) is entered into as of September 24, 2019 among AEGERION PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), AMRYT PHARMA HOLDINGS PLC, a company incorporated in England and Wales with company number 12107859 (to be renamed on or around the date hereof as AMRYT PHARMA PLC) (the “Parent”), each Lender (as hereinafter defined) from time to time party hereto and CANTOR FITZGERALD SECURITIES, as administrative agent and collateral agent for the Lenders (in such capacities, together with any successor administrative agent and collateral agent, the “Administrative Agent”).
CREDIT AGREEMENTCredit Agreement • August 27th, 2019
